Journal of Diabetes and Clinical Studies


A Novel Mixture of δ-Tocotrienol, Vitamin D3, Resveratrol (NS-3) Significantly Decreases Diabetes Biomarkers Including Inflammatory in People with Type 2 Diabetes

Author(s): Asaf A Qureshi, Dilshad A. Khan, Wajiha Mahjabeen, Neerupma Silswal, and Nilofer Qureshi

Aims: Diabetes mellitus is a metabolic disorder identified by hyperglycemia due to insulin resistance. Impaired serum/plasma fasting glucose, HbA1c, hs-CRP are biomarkers, normally used to determine onset of diabetes. δ-Tocotrienol, vitamin D3, and resveratrol (nutritional supplement-NS-3) are potent anti-cholesterolemic, anti-oxidative and anti-inflammatory agents. We hypothesized that a mixture of δ-tocotrienol, vitamin D3, resveratrol (NS-3) will be more effective treatment for reducing diabetes biomarkers as compared to its individual components, in people with type 2 diabetes mellitus (T2DM). 
Methods: To test our hypothesis, evaluation of NS-3 mixture and its individual components was carried out on diabetes inflammatory biomarkers using peripheral blood mononuclear cells (PBMC) obtained from healthy, normal and people with T2DM. A randomized placebo controlled double-blinded prospective trial of individual components (n = 30/component), and NS-3 trial of people with T2DM (n = 56/group), were given two capsules/d of cellulose/olive oil as placebo, individual components, or NS-3 mixture for 24-weeks.
Results: Significant down-regulation (15 - 74; P <0.002) of gene expression was observed with individual components and NS-3 on diabetes biomarkers (IRS-1, SOD-2, GCKR, ICAM-1, VCAM- 1, IL-6, IL-8) in PBMCs of T2DM, and in serum values of fasting glucose (11%), HbA1c (10%), hs-CRP (23%), fasting insulin (9%), HOMA-IR (20%), MDA (20%) of NS-3 treated people with T2DM after 24-weeks. Treatment with individual components showed significant decrease but were less effective than the mixture. RT-PCR analysis of blood RNA obtained from NS-3 treated people with T2DM for 24-weeks resulted in significant (p < 0.01) down-regulation of gene expression in diabetes biomarkers (IRS-1, SOD-2, GCKR, IGFBP-2) compared to pre-dose values. 
Conclusions: Present results of in vitro and in vivo studies support our hypothesis that NS-3 mixture is more effective in lowering serum levels of several diabetes biomarkers including inflammatory gene expression markers compared to its individual components in people with T2DM.

Mission and Vision Membership Withdrawal Policy Submit Paper Publication ethics
Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License © 2018